Survey says most want disclosure of gifts to docs

Share this article:

Sixty-eight percent of Americans surveyed said they are “very likely” or “somewhat likely” to support legislation requiring pharma companies to disclose gifts to doctors.

The telephone survey was conducted for Community Catalyst's Prescription Project by International Communications Research. Between June 4 and June 8, a total of 1,009 adults aged 18 and older responded, according to the study. The survey asked participants to respond to questions via Likert scale in an attempt to gage the public consensus on corporate gifts to physicians.

The findings suggest that 64% of the survey participants consider the “importance of knowing physician's financial ties to pharma companies” to be “very important (33%)” or “somewhat important (31%).” However, 55% of those surveyed reported it “somewhat unlikely (13%)” or “very unlikely (42%)” that they would ask a doctor directly about his or her relationship with pharma companies, according to the data.

When asked which types of gifts should not be allowed, 86% of respondents said travel expenses, while 51% said free drug samples should not be allowed. 
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low ...

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...